Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer
Journal of Cellular Biochemistry (2010) - Comments
pubmed: 20213764  doi: 10.1002/jcb.22523  issn: 1097-4644  issn: 0730-2312 

Shadan Ali, Sanjeev Banerjee, Jacqueline M. Schaffert, Bassel F. El-Rayes, Philip A. Philip, Fazlul H. Sarkar